Dr Fiona Walter, Department of Public Health and Primary Care, has co-authored a study into patient preferences for diagnostic testing for colorectal, lung, and pancreatic cancers in primary-care attendees. The study is published in The Lancet Oncology, and funded by an NIHR Programme Grant for Applied Research.
Using the body’s own defences to kill cancer cells
New research, led by Professor Douglas Fearon, Cancer Research UK, Cambridge Institute has identified how the ‘wall’ around cancer tumours functions and how to break it down, enabling the body’s own defences to reach and kill the cancer cells within. The method uses a drug (AMD3100, also known as Plerixafor) to break down the protective […]
Researchers find Genetic mutation that causes obesity
Researchers from the University of Cambridge and Boston Children’s Hospital have discovered a genetic cause of severe obesity which, although rare, raises new questions about weight gain and energy use. To investigate the gene in humans, Dr Joseph Majzoub, Chief of Endocrinology at Boston Children’s Hospital and lead investigator on the study, collaborated with Professor […]
Professor Hugh Markus joins the Clinical School
We are pleased to announce that Professor Hugh Markus will be joining us on 1st August as Professor of Stroke Medicine. He was previously at St George’s University of London where he was head of the Stroke and Dementia Research Centre and an honorary Neurologist at St George’s Hospital. His research interests are primarily in applying […]
New £3m centre for Cambridge heart researchers
Heart researchers from Cambridge University have received £3 million from the British Heart Foundation (BHF) to fund a BHF Centre of Research Excellence for the next five years. Cambridge is just one of six centres in the UK to be awarded Centre of Excellence funding. The Cambridge BHF Centre of Research Excellence will be a […]
MRC Award for Primary Biliary Cirrhosis Research
A £6 million programme, funded by Industry and the MRC, to carry out the largest ever study to develop new treatments and improve existing therapy for patients with a life threatening liver disease, Primary Biliary Cirrhosis (PBC) has been awarded to four centres in the UK – Cambridge, Newcastle, Imperial College and Birmingham. £5 million […]
$11m raised to develop new anticoagulant drug
A new spin-out company from the University of Cambridge and Addenbrooke’s Hospital, XO1 Ltd, has raised $11m to develop an anticoagulant drug with the potential to save millions of lives by preventing heart attacks without causing bleeding, the side effect of all antithrombotic agents such as warfarin. The drug Ichorcumab is a synthetic antibody based […]
New drug could protect from tissue damage following heart attack
Clinical Trials UnitScientists led by the University of Cambridge and the Medical Research Council (MRC) have developed a new drug that could help reduce the tissue damage that occurs following a heart attack, stroke or major surgery. Tests in mice have shown that the compound, called MitoSNO, protects heart tissue from reperfusion injury, which occurs […]
- « Previous Page
- 1
- …
- 27
- 28
- 29
